Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 9/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | IRAK1 | P51617 | 1/20 | 0.39 |
| ▸ | IRAK3 | Q9Y616 | 1/20 | 0.39 |
| ▸ | DDB1 | Q16531 | 5/20 | 0.39 |
| ▸ | KIF11 | P52732 | 3/20 | 0.38 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.38 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.36 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29648286 | 1.00 | CRBN (0.54) | CRBNMEN1ALDH1A1MAPTALOX15 | |
| SCHEMBL30962345 | 0.87 | CRBN (0.46) | CRBNMEN1ALDH1A1MAPTALOX15 | |
| SCHEMBL29648313 | 0.86 | IRAK1 (0.49) | CRBNMEN1ALDH1A1MAPTALOX15 | |
| SCHEMBL24501659 | 0.86 | IRAK1 (0.49) | CRBNMEN1ALDH1A1MAPTALOX15 | |
| SCHEMBL27176453 | 0.84 | CRBN (0.48) | CRBNMEN1ALDH1A1MAPTALOX15 | |
| SCHEMBL26139423 | 0.82 | CRBN (0.47) | CRBNMEN1ALDH1A1MAPTALOX15 | |
| SCHEMBL30042811 | 0.82 | CRBN (0.47) | CRBNMEN1ALDH1A1MAPTALOX15 | |
| SCHEMBL31129408 | 0.81 | CRBN (0.52) | CRBNMEN1ALDH1A1MAPTALOX15 | |
| SCHEMBL20231891 | 0.81 | CRBN (0.52) | CRBNMEN1ALDH1A1MAPTALOX15 | |
| SCHEMBL29522041 | 0.81 | CRBN (0.46) | CRBNMEN1ALDH1A1MAPTALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240252658-A1 | BIFUNCTIONAL PROTAC-TYPE COMPOUNDS TARGETING PXR, METHOD FOR PREPARING SAME AND THERAPEUTIC USE THEREOF | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2024-08-01 | — | — | US | disclosed |
| WO-2024127022-A1 | HETEROCYCLIC COMPOUNDS TARGETING THE NUDT5 PROTEIN | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2024-06-20 | — | — | WO | disclosed |
| EP-4340887-A1 | BIFUNCTIONAL PROTAC-TYPE COMPOUNDS TARGETING PXR, METHOD FOR PREPARING SAME, AND THERAPEUTIC USE THEREOF | Centre National de la Recherche Scientifique (FR) | 2024-03-27 | — | — | EP | disclosed |
| CN-117295523-A | PXR-targeted difunctional PROTAC compound, preparation method and therapeutic application thereof | 国家科学研究中心 | 2023-12-26 | — | — | CN | disclosed |
| WO-2022243365-A1 | BIFUNCTIONAL PROTAC-TYPE COMPOUNDS TARGETING PXR, METHOD FOR PREPARING SAME, AND THERAPEUTIC USE THEREOF | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2022-11-24 | — | — | WO | disclosed |
| WO-2022120355-A1 | TEAD DEGRADERS AND USES THEREOF | Ikena Oncology, Inc. (US) | 2022-06-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240252658-A1 | BIFUNCTIONAL PROTAC-TYPE COMPOUNDS TARGETING PXR, METHOD FOR PREPARING SAME AND THERAPEUTIC USE THEREOF | ADRM1, PSME3, PSME1 | CRBN 167/4885MEN1 3576/4885ALDH1A1 3809/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.